Bonita David P's Form 4 filing
Prelude Therapeutics Inc (PRLD) · filed Apr 23, 2026
- Accession no.
- 0000947871-26-000462
- Filed
- Apr 23, 2026
- Trade date
- Apr 21, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $12.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonita David PCIK 0001572451 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Common Stock | PPurchaseAcquired | +1,689,189 | $4.44 | +$7,499,999.16 | 11,808,945 | Indirect | |
| Apr 21, 2026 | Common Stock | PPurchaseAcquired | +1,126,126 | $4.44 | +$4,999,999.44 | 1,126,126 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.